VeChain falls nearly 9% as overbought momentum fades and selling pressure rises

VeChain falls nearly 9% as overbought momentum fades and selling pressure rises
VeChain slides 8.77% today

VeChain (VET) slid 8.77% on the day as overbought technical momentum faded and selling pressure intensified. The downturn is reinforced by VET remaining below its long-term moving average, even as shorter-term signals show pockets of bullish momentum.

VET price prediction
24H 1.38%
$0.0075085
48H -4.24%
$0.007092
7D -11.13%
$0.0065815
1M 5.6%
$0.0078205
3M -25.55%
$0.00551383
6M -50.66%
$0.00365398
12M -6.42%
$0.00693027
Current price: $0.007406 -0.000599 7.48%
Real-time Data 22:42
Daily range 0.007525 Arrow from to Icon 0.00808
Weekly range 0.00723000 Arrow from to Icon 0.00888000
Loading...

Highlights

  • VET/USD trades above its 20-day and 50-day moving averages but remains below the 200-day average, indicating bullish short-term momentum and bearish long-term alignment.
  • Momentum indicators are mixed, with buy signals from MACD and RSI but overbought signals from Stochastic RSI and CCI, suggesting elevated risk of a near-term pullback.
  • Price stands at $0.005386, with a projected 5-day range of $0.0044785 to $0.006779 and a 77% probability of an upward move.
Anton Kharitonov, expert at Traders Union, views the latest VET pullback as a warning sign. He notes the persistent inability to regain the 200-day moving average reflects structural weakness. Despite short-term momentum, deep overbought signals and a fading trend raise concerns. The absence of positive news also weakens the fundamental outlook. "With selling pressure building and long-term resistance holding strong, I advise caution and expect further downside risk if key supports fail."
Viktoras Karapetjanc, expert at Traders Union, believes the bullish structure for VET remains largely intact. He points out that strong buy indications and elevated momentum readings support a constructive view. The market’s recent retreat offers new potential entry points for optimistic traders. While news flows are muted, technical setups provide clear targets for further growth. "A decisive break above $0.005521 could open the path to the upper band, and I expect further positive movement in the coming sessions."
Parshwa Turakhiya, analyst, sees a mixed but opportunity-filled landscape for VET. He observes high RSI and overbought conditions, suggesting possible pullbacks, yet notes recent intraday buyer strength. Consolidation around current levels could trigger swift short-term setups. "For now, I’m watching volatility bands closely — quick moves in either direction may offer compelling sentiment-driven trades."
VeChain asset chart
VeChain price dynamics. Source: TradingView.

Short-term bullish structure meets mixed signals and overbought risk

VET/USD is trading above both the 20-day and 50-day moving averages ($0.0047502 and $0.00474948), but below the 200-day moving average at $0.0062201. This highlights continued short- and medium-term bullish alignment, but a weak long-term structure. The Ichimoku Kijun at $0.00526 offers near-term structural support, with resistance set at $0.005521. Momentum readings are mixed: MACD signals a buy, but ADX suggests the trend is weak. RSI is elevated at 79.94, supporting a buy bias, as both Stochastic RSI and CCI are deeply overbought, presenting short-term pullback risk. Bull/Bear Power at 0.00120337 shows intraday buyer dominance, though the Awesome Oscillator remains neutral. The price is near the session low with intraday volatility at 4.87%. Overbought momentum contrasts with today's retreat, raising the probability of further cooling in the near term.

Earlier, analysts noted that VeChain’s technical setup favored sideways consolidation with potential upside if resistance was cleared. The current analysis adds that while long-term structure remains weak, traders should closely monitor a break of $0.005521 for signals of directional momentum in the days ahead.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.